Laird Norton Wetherby Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-18,050
| Closed | -$3.2M | – | 766 |
|
|
2020
Q1 | $3.2M | Buy |
18,050
+12,811
| +245% | +$2.41M | 0.36% | 58 |
|
|
2019
Q4 | $1M | Sell |
5,239
-12,138
| -70% | -$2.19M | 0.1% | 214 |
|
|
2019
Q3 | $2.92M | Buy |
17,377
+1,738
| +11% | +$283K | 0.31% | 71 |
|
|
2019
Q2 | $2.62M | Sell |
15,639
-238
| -1% | -$33K | 0.29% | 77 |
|
|
2019
Q1 | $2.33M | Buy |
15,877
+653
| +4% | +$94.7K | 0.29% | 77 |
|
|
2018
Q4 | $2.04M | Sell |
15,224
-2,229
| -13% | -$365K | 0.29% | 75 |
|
|
2018
Q3 | $3.32M | Buy |
17,453
+1,816
| +12% | +$334K | 0.41% | 48 |
|
|
2018
Q2 | $2.61M | Sell |
15,637
-10,020
| -39% | -$1.61M | 0.35% | 61 |
|
|
2018
Q1 | $4.32M | Buy |
25,657
+1,142
| +5% | +$192K | 0.6% | 27 |
|
|
2017
Q4 | $4.01M | Sell |
24,515
-2,556
| -9% | -$459K | 0.56% | 34 |
|
|
2017
Q3 | $5.55M | Buy |
27,071
+314
| +1% | +$73K | 0.83% | 18 |
|
|
2017
Q2 | $6.5M | Sell |
26,757
-784
| -3% | -$184K | 1.11% | 11 |
|
|
2017
Q1 | $6.58M | Buy |
27,541
+2,067
| +8% | +$481K | 1.18% | 9 |
|
|
2016
Q4 | $5.35M | Sell |
25,474
-2,149
| -8% | -$445K | 1.05% | 13 |
|
|
2016
Q3 | $6.36M | Buy |
27,623
+1,134
| +4% | +$277K | 1.29% | 9 |
|
|
2016
Q2 | $6.12M | Sell |
26,489
-167
| -0.6% | -$38.5K | 1.36% | 9 |
|
|
2016
Q1 | $7.14M | Sell |
26,656
-210
| -0.8% | -$60.1K | 1.68% | 7 |
|
|
2015
Q4 | $8.39M | Buy |
26,866
+179
| +0.7% | +$53.3K | 2.01% | 5 |
|
|
2015
Q3 | $7.25M | Buy |
26,687
+130
| +0.5% | +$39.9K | 1.86% | 5 |
|
|
2015
Q2 | $8.06M | Sell |
26,557
-159
| -0.6% | -$47.4K | 1.94% | 4 |
|
|
2015
Q1 | $7.95M | Buy |
26,716
+2,584
| +11% | +$737K | 1.94% | 5 |
|
|
2014
Q4 | $6.21M | Buy |
24,132
+551
| +2% | +$138K | 1.56% | 9 |
|
|
2014
Q3 | $5.69M | Buy |
23,581
+1,374
| +6% | +$307K | 1.59% | 9 |
|
|
2014
Q2 | $4.95M | Buy |
22,207
+115
| +0.5% | +$23.8K | 1.4% | 9 |
|
|
2014
Q1 | $4.55M | Buy |
22,092
+221
| +1% | +$43.8K | 1.3% | 10 |
|
|
2013
Q4 | $3.67M | Buy |
21,871
+83
| +0.4% | +$13K | 1.05% | 16 |
|
|
2013
Q3 | $3.14M | Buy |
21,788
+23
| +0.1% | +$3.06K | 0.98% | 19 |
|
|
2013
Q2 | $2.75M | Buy |
+21,765
| New | +$2.46M | 0.96% | 21 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Laird Norton Wetherby Wealth Management's AGN Position: Q2 2020 in Review
Laird Norton Wetherby Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 18,050 shares — an estimated $3.2M sold.
Laird Norton Wetherby Wealth Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $8.39M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Laird Norton Wetherby Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Laird Norton Wetherby Wealth Management sold 18,050 Allergan plc shares in Q2 2020, an estimated $3.2M.
- Laird Norton Wetherby Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Laird Norton Wetherby Wealth Management's Allergan plc position peaked at $8.39M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.